From artificial intelligence to autonomous sterilization robots to drones, emerging technologies are playing a strong role in combating COVID-19.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
The future of eye care will sit at the intersection of the digital and physical worlds.
It is the pot of gold at the end of the medical rainbow—the promise that, by harnessing data, researchers can tailor drugs, devices, and treatments to the genetic configuration, lifestyle, and environment of individual patients.
A rapidly aging population, along with economic growth and rising industrialization, is driving a big increase of the disease.
This mode of personalized medicine helps doctors make more informed decisions related to drug therapies.
Digital reality technologies are fast emerging as promising tools to aid physicians and patients. Western and Asian medtech companies are becoming big players in the growing market for these new applications in Asia.
Although many device companies are seeking cost savings when seeking sourcing products or components manufactured in Asia, quality should not be compromised. Intense due diligence is important.